The RBA is returning interest rates to normal and this month’s minutes suggest the process will no longer be gradual.
JP Morgan sees risks across the market to current profit forecasts, UBS sees value in utilities and Weres adds two copper stocks to its Conviction List.
Many in the market are expecting CSL to deliver solid earnings growth in coming years but Morgan Stanley suggests earnings risk is actually to the downside.
Oz Minerals beat market expectations for production and costs in the March quarter and forecasts have increased.
Bank of Queensland’s result was sufficiently in line with expectations but analysts suggest management’s return on equity guidance is a bit of a stretch.
Citi has initiated coverage on QRxPharma, seeing significant upside potential as the company develops its products designed for the moderate-to-severe pain relief market.
RBS looks at the US reporting season now underway while GSJB Were assesses earnings risk to local companies, plus more.
Morgan Stanley has initiated on 10 emerging companies with nine positive ratings, while both JP Morgan and Credit Suisse have also identified value elsewhere in the sector.
Macquarie notes a sharp drop off in sales of electronic goods while Merrill Lynch downgrades all food retailers.
Deutsche becomes the latest broker to query bank earnings forecasts while RBS evaluates NAB’s latest UK moves.